Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

Pf89 Feb. 21 at 12:23 AM

$PFE Russia's Enteromix is an interesting one. Especially if it indeed will be available for free for the Russian people. Serbia wants it ,and most likely China will approve it as well. Any thoughts on that?

0 · Reply

MrPfizer Feb. 21 at 12:06 AM

$PFE who cares what price is day in day out, it will be 90$ by 229

1 · Reply

SniperPro Feb. 20 at 11:10 PM

$TSLA $NVDA $LXRX $NVO $PFE Bulls & Bears step inside my wondering world... Honest question — and please don’t reply with sarcasm; we’re adults. We ain't 18 anymore.. In over 30 years of trading and investing professionally, I’ve never believed in gaps. In fact, some of my close friends who work at some of the largest trading firms and hedge funds don’t believe in gaps anymore either. At this point, it feels more like an old wives’ tale. AI has corrupted our trading systems and manipulates them according to trading rules, plus or minus 10%, from what I gather. Do you still believe we’re operating in a fair marketplace? & Remember... Enjoy your weekend. Life is beautiful when we slow down and take the time to enjoy it. ...

2 · Reply

taxplanr Feb. 20 at 10:47 PM

$MRNA $BNTX $PFE can't escape their trail of death https://freenz.substack.com/p/dr-joseph-sansone-key-witness-in?utm_source=cross-post&publication_id=649762&post_id=188595736&utm_campaign=1021940&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

Micheal_Pothead Feb. 20 at 8:09 PM

$PFE insane manipulation to get it to 26.50 wow

1 · Reply

TaintMcBalls Feb. 20 at 6:29 PM

Dividends on chain are juicier Make sure you are watching $VRTS $ETD $UVV $PFE

0 · Reply

ZacksResearch Feb. 20 at 6:29 PM

$AZN vs. $PFE — Growth or value in 2026? 👀 AZN’s stronger growth outlook and ambitious 2030 revenue target could give it the edge, while PFE counters with a higher yield and cheaper valuation. It’s a classic momentum vs. income setup heading into 2026. Which pharma giant fits your strategy better? Full breakdown here 👉 https://www.zacks.com/stock/news/2872955/astrazeneca-vs-pfizer-which-pharma-giant-has-the-edge-in-2026?cid=sm-stocktwits-2-2872955-teaser-34501&ADID=SYND_STOCKTWITS_TWEET_2_2872955_TEASER_34501

0 · Reply

DragonAlgo Feb. 20 at 6:28 PM

🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-02-20 | Strike: $25.00 | Type: CALL Option Plan (premium): Entry: $1.55 Stop: $1.12 TP1: $2.02 TP2: $2.64 TP3: $3.73 🔗 https://dragonalgo.com

0 · Reply

gargoyl Feb. 20 at 5:57 PM

$BLRX 👀 🦍 It’s about get Interesting up in 👂hear $REGN $PFE $VSTM

0 · Reply

ZacksResearch Feb. 20 at 5:29 PM

$PFE vs. $AZN: Which Pharma Giant Holds More Promise? 🤔 Pfizer's facing a rocky road with declining COVID sales and looming patent cliffs, but its strong pipeline and strategic acquisitions aim to offset these challenges. AstraZeneca's growth targets and robust pipeline shine despite some challenges. AZN’s stock has soared 40.6% over the past year, far outpacing PFE’s 1.8% rise. Full analysis here 👉 https://www.zacks.com/stock/news/2872955/astrazeneca-vs-pfizer-which-pharma-giant-has-the-edge-in-2026?cid=sm-stocktwits-2-2872955-body-34502&ADID=SYND_STOCKTWITS_TWEET_2_2872955_BODY_34502

0 · Reply

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 11:30 AM EST - 2 days ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 17, 2026, 5:42 PM EST - 3 days ago

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 6:45 AM EST - 3 days ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 13, 2026, 6:13 AM EST - 7 days ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

Feb 12, 2026, 8:05 AM EST - 8 days ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Feb 11, 2026, 6:08 PM EST - 9 days ago

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 4:06 PM EST - 9 days ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Feb 11, 2026, 8:56 AM EST - 9 days ago

Is Pfizer Stock Now A Value Trap?

Feb 10, 2026, 3:20 PM EST - 10 days ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 8, 2026, 10:19 PM EST - 11 days ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 6, 2026, 2:55 PM EST - 14 days ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 7:25 AM EST - 14 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

Feb 6, 2026, 6:45 AM EST - 14 days ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 5, 2026, 7:09 PM EST - 15 days ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 3, 2026, 3:00 PM EST - 17 days ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 2:02 PM EST - 17 days ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 1:27 PM EST - 17 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Feb 3, 2026, 12:00 PM EST - 17 days ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 11:56 AM EST - 17 days ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:17 AM EST - 17 days ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Feb 3, 2026, 10:15 AM EST - 17 days ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 8:50 AM EST - 17 days ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:17 AM EST - 17 days ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 7:28 AM EST - 17 days ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:21 AM EST - 17 days ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:18 AM EST - 17 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:02 AM EST - 17 days ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 6:57 AM EST - 17 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:50 AM EST - 17 days ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:45 AM EST - 17 days ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 17 days ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Feb 3, 2026, 6:40 AM EST - 17 days ago

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Feb 2, 2026, 8:42 AM EST - 18 days ago

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

SNY

Feb 2, 2026, 1:01 AM EST - 18 days ago

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Jan 31, 2026, 3:47 AM EST - 20 days ago

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

BBY CAG EQR FRT KEY LYB MAA

Jan 30, 2026, 10:31 AM EST - 21 days ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 7:30 AM EST - 21 days ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Jan 29, 2026, 9:00 AM EST - 22 days ago

Pfizer: A High-Yield Pharma At A Turning Point

Jan 27, 2026, 4:52 PM EST - 24 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

ABBV LLY

Jan 27, 2026, 7:40 AM EST - 24 days ago

Pfizer vs. Merck Stock And JNJ

Jan 27, 2026, 6:02 AM EST - 24 days ago

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Jan 23, 2026, 10:33 AM EST - 4 weeks ago

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

Jan 23, 2026, 9:54 AM EST - 4 weeks ago

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

AGNC AGNCP ARLP ECC EFC ET FBRT

Jan 20, 2026, 12:34 PM EST - 4 weeks ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:18 PM EST - 4 weeks ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Jan 20, 2026, 7:11 AM EST - 4 weeks ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Jan 20, 2026, 2:19 AM EST - 4 weeks ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 19, 2026, 8:10 PM EST - 4 weeks ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

Jan 19, 2026, 2:20 PM EST - 4 weeks ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

Pf89 Feb. 21 at 12:23 AM

0 · Reply

MrPfizer Feb. 21 at 12:06 AM

$PFE who cares what price is day in day out, it will be 90$ by 229

1 · Reply

SniperPro Feb. 20 at 11:10 PM

2 · Reply

taxplanr Feb. 20 at 10:47 PM

0 · Reply

Micheal_Pothead Feb. 20 at 8:09 PM

$PFE insane manipulation to get it to 26.50 wow

1 · Reply

TaintMcBalls Feb. 20 at 6:29 PM

Dividends on chain are juicier Make sure you are watching $VRTS $ETD $UVV $PFE

0 · Reply

ZacksResearch Feb. 20 at 6:29 PM

0 · Reply

DragonAlgo Feb. 20 at 6:28 PM

0 · Reply

gargoyl Feb. 20 at 5:57 PM

$BLRX 👀 🦍 It’s about get Interesting up in 👂hear $REGN $PFE $VSTM

0 · Reply

ZacksResearch Feb. 20 at 5:29 PM

0 · Reply

dewmoore Feb. 20 at 5:08 PM

$SLS shouts out to my good guy over at Reddit -- he gave me a tip last night but I had to wait until he posted it --- well he's posted it! WTF is NIH??? Secret "CANCER" MEETINGS held this week: Why this is AIN'T normal: Federal law typically requires a 15-to-30-day notice. The NIH explicitly used "Exceptional Circumstances" to bypass these rules and hold these cancer meetings now.. LFG! Now that's NEW shit I haven't seen or heard all week ! Hey $PFE $ABBV $MRK my Jan. calls are waiting on that $100+ Hell fucking yeah he nailed that shit ! https://www.reddit.com/r/TheRaceTo10Million/comments/1ra0vbv/sls_the_secret_meetings_100_bidding_war_over/

3 · Reply

edlu77 Feb. 20 at 4:25 PM

$PFE This is never up on big green days. Pfizer be Pfizering

1 · Reply

Micheal_Pothead Feb. 20 at 3:52 PM

$PFE this is pathetic I’m sorry

1 · Reply

erevnon Feb. 20 at 3:45 PM

Barclays initiates coverage on Pfizer $PFE at Underweight rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

reyofhope Feb. 20 at 3:42 PM

$PFE I guess I'm here for the dividends maybe it's not a bad idea at all look at stocks like Oracle and Netflix. It's safer here.

1 · Reply

Willieberich Feb. 20 at 3:39 PM

$PFE to many negative people on twits ..let this come down to 26 area .this would still remain in an uptrend since April 8th .don't get your info from twit heads..26 is where I'll add more .still way up .here Goodluck people..

0 · Reply

Micheal_Pothead Feb. 20 at 3:20 PM

$PFE every index is green lol

0 · Reply

ItsCarRamRod Feb. 20 at 3:20 PM

$PFE as long as Bourla the wealth destroyer is in charge PFE will be a terrible investment.

1 · Reply

Gj64 Feb. 20 at 3:15 PM

$PFE

0 · Reply

taxplanr Feb. 20 at 3:06 PM

$BNTX $MRNA $PFE $MRK $BMY have no cowbell Dr Pat has the LA Times

0 · Reply

SeriouslyWhy Feb. 20 at 2:53 PM

$PFE fake market

0 · Reply

_TP888 Feb. 20 at 2:46 PM

$PFE | $24.50 | Put | Premium: $436K Ask-heavy - aggressive put buyers. Offers disappeared.

0 · Reply

Market Cap	155.62B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.47
Forward PE	9.22
Profit Margin	12.42%
Debt to Equity Ratio	0.66

Volume	44,786,900
Avg Vol	49,559,352
Day's Range	N/A - N/A
Shares Out	5.69B
Stochastic %K	61%
Beta	0.47
Analysts	Sell
Price Target	$28.73